盐酸曲美他嗪治疗冠心病稳定型心绞痛的临床疗效观察

Clinical Efficacy of Trimetazidine Hydrochloride in the Treatment of Coronary Heart Disease Stable Angina Pectoris

目的:评价盐酸曲美他嗪治疗冠心病稳定型心绞痛的预后效果。方法:选择我院2016~2018年期间收治的80例冠心病稳定型心绞痛患者,随机分为常规抗心绞痛综合治疗的对照组以及加行盐酸曲美他嗪治疗的观察组。结果:观察组患者治疗总有效率高于对照组,指标结果优于对照组,腹痛、腹泻不良反应差异显著,P>0.05。结论:冠心病稳定型心绞痛治疗期间加行盐酸曲美他嗪治疗效果显著。

Objective:To evaluate the prognostic effect of trimetazidine hydrochloride in the treatment of coronary heart disease stable angina pectoris.Methods:80 patients with stable angina pectoris treated in our hospital from 2016 to 2018 were randomly divided into the control group with conventional anti-angina pectoris and the observation group treated with adding trimetazidine hydrochloride.Results:The total effective rate of the observation group was higher than that of the control group.The index results were superior to the control group.The adverse reactions of abdominal pain and diarrhea were significant,P>0.05.Conclusion:The effect of adding trimetazidine hydrochloride during the treatment of stable angina pectoris is significant.